ConductScience.org, home

Paper33501656

A plant-derived TRPV3 inhibitor suppresses pain and itch.

Han Y and 7 others. Br J Pharmacol, 2021. Cited by 50 papers, by iCite.

Cite this record

ConductScience Library. A plant-derived TRPV3 inhibitor suppresses pain and itch. Papers, record 33501656. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33501656

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A plant-derived TRPV3 inhibitor suppresses pain and itch.
PubMed
Journal
Br J Pharmacol
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
50
iCite
Relative citation ratio, by iCite
3.55
iCite
Revised in PubMed
2022-05-31
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Han YYalan
2Luo AAnna
3Kamau PMPeter Muiruri
4Takomthong PPitchayakarn
5Hu JJingmei
6Boonyarat CChantana
7Luo LLei
8Lai RRen

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Plant PreparationsMajor topic
PruritusMajor topic
TRPV Cation ChannelsMajor topic
Animals
Disease Models, Animal
Mice
Pain
Rutaceae
Skin

Source PubMed

Download CSV of topics

Grants15

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
KC Wong Education FoundationChinese Academy of SciencesPubMed
KFJ-STS-SCYD-304Chinese Academy of SciencesPubMed
XDB31000000Chinese Academy of SciencesPubMed
Youth Innovation Promotion AssociationChinese Academy of SciencesPubMed
ZSTH-034Chinese Academy of SciencesPubMed
"Light of West China" ProgramChinese Academy of SciencesPubMed
21761142002National Natural Science Foundation of ChinaPubMed
31900332National Natural Science Foundation of ChinaPubMed
31930015National Natural Science Foundation of ChinaPubMed
2019-YT-053Science and Technology Department of Yunnan ProvincePubMed
2019ZF003Science and Technology Department of Yunnan ProvincePubMed
202001AT070121Science and Technology Department of Yunnan ProvincePubMed
202001AW070015Science and Technology Department of Yunnan ProvincePubMed
202003AD150008Science and Technology Department of Yunnan ProvincePubMed
2018YFA0801403the Ministry of Science and Technology of ChinaPubMed

Source PubMed

Download CSV of grants

Cited by38

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.

PMIDTitleJournalYearIn PapersSource
42589711Amelioration of Atopic Dermatitis by Frankincense Oil Extract Is Associated with TRPV3 Regulation and Cutaneous Inflammation Suppression.Int J Mol Sci2026https://conductscience.org/library/papers/42589711PubMed
42169632Mechanisms of pruritus and advances in traditional Chinese medicine therapy (Review).Mol Med Rep2026https://conductscience.org/library/papers/42169632PubMed
41880378Inhibition of transient receptor potential vanilloid 1 (TRPV1) by a novel selective antagonist for anti-nociceptive effect on inflammatory pain without hyperthermia.PLoS One2026https://conductscience.org/library/papers/41880378PubMed
41787805HaloTag-based approach to quantify subcellular localization of TRPV3 channels.Biophys J2026https://conductscience.org/library/papers/41787805PubMed
41781621A metabolic alarmin from keratinocytes potentiates systemic humoral immunity.Nature2026https://conductscience.org/library/papers/41781621PubMed
41422779Activation of TRPV3 channels in bladder cancer cells stimulates ATP release.Mol Pharmacol2026https://conductscience.org/library/papers/41422779PubMed
41166019Modulatory effects of bioactive natural compounds on pruritic pathways: mechanistic basis and therapeutic prospects.Inflammopharmacology2025https://conductscience.org/library/papers/41166019PubMed
41118703Physiological functions and pharmacological targeting of transient receptor potential channels.Pharmacol Rev2025https://conductscience.org/library/papers/41118703PubMed
40831235Advances in Atopic Dermatitis Treatment: From Pathogenesis to Natural Product-Based Therapies.Phytother Res2025https://conductscience.org/library/papers/40831235PubMed
40699677Repositioning Fluoxetine as a TRPV3 Channel Inhibitor to Alleviate Skin Inflammation and Pruritus.Curr Issues Mol Biol2025https://conductscience.org/library/papers/40699677PubMed
40534677Proteins from Stressed Mesenchymal Stem Cells Can Repair Hair Follicles and Promote Hair Regeneration.ACS Pharmacol Transl Sci2025https://conductscience.org/library/papers/40534677PubMed
40288993Activation of transient receptor potential vanilloid 3 is required for keratinocyte differentiation and epidermal barrier formation.Korean J Physiol Pharmacol2025https://conductscience.org/library/papers/40288993PubMed
40141324The Impact of a Quinone Scaffold on Thermo-TRPs Modulation by Dimethylheptyl Phytocannabinoids.Int J Mol Sci2025https://conductscience.org/library/papers/40141324PubMed
39837134TRPV3 in skin thermosensation and temperature responses.J Physiol Sci2025https://conductscience.org/library/papers/39837134PubMed
39757673Advances in the Study for Modulators of Transient Receptor Potential Vanilloid (TRPV) Channel Family.Curr Top Med Chem2025https://conductscience.org/library/papers/39757673PubMed
39424975Molecular and cellular mechanisms of itch sensation and the anti-itch drug targets.Acta Pharmacol Sin2025https://conductscience.org/library/papers/39424975PubMed
39202808Inhibition of Cutaneous TRPV3 Channels by Natural Caffeic Acid for the Alleviation of Skin Inflammation.Molecules2024https://conductscience.org/library/papers/39202808PubMed
38254707Site-Specific Transient Receptor Potential Channel Mechanisms and Their Characteristics for Targeted Chronic Itch Treatment.Biomolecules2024https://conductscience.org/library/papers/38254707PubMed
38154600Selective inhibition of overactive warmth-sensitive Ca2+-permeable TRPV3 channels by antispasmodic agent flopropione for alleviation of skin inflammation.J Biol Chem2024https://conductscience.org/library/papers/38154600PubMed
38139833Targeting Transient Receptor Potential (TRP) Channels, Mas-Related G-Protein-Coupled Receptors (Mrgprs), and Protease-Activated Receptors (PARs) to Relieve Itch.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/38139833PubMed

See all 38 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TRPV3162514PubTator's text mininghttps://conductscience.org/library/genes/162514

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33501656

GET https://conductscience.org/api/papers/v1/33501656/cited_by?page=2